Summary of Amphotericin B (AmB) formulations.
. | AmB . | L-AmB . | ABLC . | ABCD . |
---|---|---|---|---|
Abbreviations: HPC, hydrogenated phosphatidylcholine; CHOL, cholesterol; DMPC, dimyristoyl phosphatidylcholine; DMPG, dimyristoyl phosphatidylglycerol | ||||
Trade Name (US) | Fungizone | AmBisome | Abelcet | Amphotec |
Lipid components | Deoxycholate | HPC/CHOL/DSPG | DMPC/DMPG | Cholesterylsulfate |
Mol % AmB | 34% | 10% | 35 % | 50% |
Standard dose | 0.5 – 1.5 mg/kg | 3-5 mg/kg | 3-5 mg/kg | 3-5 mg/kg |
Relative nephrotoxicity | ++++ | + | ++ | ++ |
Infusion related toxicity | +++ | + | ++ | ++ |
. | AmB . | L-AmB . | ABLC . | ABCD . |
---|---|---|---|---|
Abbreviations: HPC, hydrogenated phosphatidylcholine; CHOL, cholesterol; DMPC, dimyristoyl phosphatidylcholine; DMPG, dimyristoyl phosphatidylglycerol | ||||
Trade Name (US) | Fungizone | AmBisome | Abelcet | Amphotec |
Lipid components | Deoxycholate | HPC/CHOL/DSPG | DMPC/DMPG | Cholesterylsulfate |
Mol % AmB | 34% | 10% | 35 % | 50% |
Standard dose | 0.5 – 1.5 mg/kg | 3-5 mg/kg | 3-5 mg/kg | 3-5 mg/kg |
Relative nephrotoxicity | ++++ | + | ++ | ++ |
Infusion related toxicity | +++ | + | ++ | ++ |